Stem cell treatment of Multiple Sclerosis

Multiple Sclerosis

Multiple sclerosis (MS) is a chronic neurological disorder that affects the central nervous system (brain and spinal cord). The disease process results in inflammation and damage to myelin (the insulating tissue for nerve fibers) and other cells within the nervous system.

Because myelin aids the conduction of nerve signals, damage to myelin results in impaired nerve signaling and may impair normal sensation, movement, and thinking. This damage occurs in patches that appear as distinct lesions on magnetic resonance imaging (MRI). The patches cause different symptoms, depending on their location within the nervous system.

The XCell-Center Multiple Sclerosis treatment

The stem cells are first collected from a patient's bone marrow, extracted from the hipbone (iliac crest) then implanted back into the body days later. Prior to re-implantation of the cells, the bone marrow is processed in one of our labs, where the quantity and quality of the stem cells is also checked.

These re-injected stem cells have the potential to transform into multiple types of cells and are capable of regenerating damaged tissue. Our innovative stem cell treatments use the self-healing potential of each patient's own body to stimulate regeneration or repair.

Currently there is no cure for MS. There are treatments available that may slow its progression and alleviate associated symptoms. Stem cell therapy is among these treatment options.

Results

In the bar chart below you can see the results of a survey of 19 of our multiple sclerosis patients. The survey was conducted one to six months after the treatment. Results from Multiple Sclerosis treatment after 1-6 months

  • Seven out of 19 patients reported no change in spasticity, sensation, mobility or feeling of well-being after the treatment.
  • Eight out of 19 patients reported an improvement, with reduced spasticity and/or improved sensation and/or improved mobility and/or a reduction in fatigue.
  • Three out of 19 patients reported a strong improvement, with an absence of spasticity and/or a marked improvement of sensation and/or marked improvement in mobility. They also reported improved bladder control and/or better vision and/or a marked reduction of fatigue.
  • One patient reported a perceived deterioration of the quality of his life. The treatment could neither stop nor reverse the advance of the MS symptoms.

Cost

The price for the intrathecal treatment is 7,545 Euros.
Under a local anesthetic, your stem cells will be injected directly into the cerebrospinal fluid via lumbar puncture.

Treatment Evaluation Process

In order to be evaluated for treatment, patients must complete an online medical history form. Once you've completed the online medical history and submitted it, a patient relations consultant will contact you. He or she will assist you with the rest of the evaluation process. Upon treatment approval, your consultant will also assist you with treatment scheduling and trip preparation.

Start the online Medical Treatment Evaluation

News
  • Stem cells and tumor risk more…
  • March 10, 2010
    Encouraging Stroke Treatment Results Now Available more…
  • March 10, 2010
    NBC News Video Feature "Small Miracles: How life has changed for Dom and H" (cerebral palsy) more…
  • March 9, 2010
    60% of Spinal Cord Injury Patients Improved - The Latest Statistics for 140 Spinal Cord Injury Patients more…
  • March 8, 2010
    XCell-Center Presents Impressive Results from Cerebral Palsy Stem Cell Treatment more…
  • February 16, 2010
    The Lewiston Morning Tribune: Stem Cell Therapy Works for Cousins more…
  • February 9, 2010
    Saving Limbs: Autologous Mesenchymal cells for the treatment of patients with critical limb ischemia – an Interim Analysis more…
  • February 4, 2010
    Autologous Stem Cell Transplantation by Lumbar Puncture: A safety Follow-up in 870 Patients more…
  • February 2, 2010
    Parkinson's Treatment Results Available Now! more…
  • December 2, 2009
    The Prescott Daily Courier features Parkinson's Patient, Aubra Phillips more…
  • October 7, 2009
    XCell-Center Commences Neuro-endoscopic Autologous Stem Cell Treatments in Germany more…
  • October 1, 2009
    Autism Patients Show Progress Following Stem Cell Therapy more…
  • TV Link: About XCell-Center more…
  • News archive 2009 more…
  • News archive 2008 more…
  • News archive 2007 more…